Market Place
Sourcing Support
Toragen Updates Data from Ph 1 Trial of TGN-S11 in HPV Cancers
18 Nov 2024 //
BUSINESSWIRE
Toragen Announced Safety Data from Cohort 2 in Papillomavirus-Induced Cancer
12 Dec 2023 //
BUSINESSWIRE
Toragen Announced Positive Safety Update from Cohort 1 of its Phase 1 Trial
06 Nov 2023 //
BUSINESSWIRE
Toragen, Inc. Announced Full Enrollment of Cohort 1 of its Phase 1 Trial
10 Oct 2023 //
BUSINESSWIRE
Toragen, Inc. Announces Initiation of Phase 1 Trial of TGN-S11 i
30 Jun 2023 //
BUSINESSWIRE
Toragen, Inc. Announces FDA Acceptance of IND Application for TGN-S11
28 Feb 2023 //
BUSINESSWIRE
Toragen, Inc. Announces Appointment of Chief Scientific Officer
08 Feb 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.